XTL Biopharmaceuticals Ltd.
Clinical-stage biopharmaceutical company developing drugs for autoimmune diseases.
XTLB | TA
Overview
Corporate Details
- ISIN(s):
- IL0010854979
- LEI:
- 529900NDDXEAPTUTXP41
- Country:
- Israel
- Address:
- 5 HaCharoshet St., 4365603 Raanana
- Website:
- https://www.xtlbio.com
- Sector:
- Manufacturing
Description
XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-05-19 21:10 |
Form 20-F/A Amendment No. 1 for the fiscal year ended December 31, 2020
|
English | 36.3 KB | ||
| 2021-05-19 21:02 |
a restatement of the XTL Biopharmaceuticals Ltd. financial statements for the y…
|
English | 113.1 KB | ||
| 2021-05-19 21:02 |
a restatement of the XTL Biopharmaceuticals Ltd. financial statements for the y…
|
English | 36.2 KB | ||
| 2021-04-06 01:15 |
results of the Extraordinary
General Meeting of shareholders of the Company, M…
|
English | 107.7 KB | ||
| 2021-04-06 01:15 |
results of the Extraordinary
General Meeting of shareholders of the Company, M…
|
English | 36.4 KB | ||
| 2021-03-30 00:49 |
postponement of annual meeting to April 5, 2021-No legal quorum
|
English | 106.8 KB | ||
| 2021-03-30 00:49 |
postponement of annual meeting to April 5, 2021-No legal quorum
|
English | 59.0 KB | ||
| 2021-03-15 18:16 |
FORM 20-F For the fiscal year ended December 31, 2020
|
English | 891.4 KB | ||
| 2021-03-15 18:16 |
FORM 20-F For the fiscal year ended December 31, 2020
|
English | 36.2 KB | ||
| 2021-02-22 22:12 |
Immediate Report of Meeting to be held on March 29,2021
|
English | 570.0 KB | ||
| 2021-02-22 22:12 |
Immediate Report of Meeting to be held on March 29,2021
|
English | 59.0 KB | ||
| 2021-01-07 18:53 |
6K-results of the Annual General Meeting held on January 07, 2021
|
English | 109.8 KB | ||
| 2021-01-07 18:53 |
6K-results of the Annual General Meeting held on January 07, 2021
|
English | 36.0 KB | ||
| 2020-12-31 19:48 |
postponement of annual meeting to January 1st, 2021-No legal quorum
|
English | 125.0 KB | ||
| 2020-11-25 19:58 |
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 31, 2020
|
English | 5.2 MB |
Automate Your Workflow. Get a real-time feed of all XTL Biopharmaceuticals Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for XTL Biopharmaceuticals Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for XTL Biopharmaceuticals Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
